Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Diabetes Complications. 2023 Aug 25;37(10):108597. doi: 10.1016/j.jdiacomp.2023.108597

Table 1.

Subject characteristics and miR-142 levels, including by Type 1 diabetes complications status. Data showed: mean ± SD, median (LQ, UQ) or mean (95% CI).

Non-diabetic All T1D T1D-No
Cx
T1D-Cx Pb

N (M/F) 33 (16/17) 69 (34/35) 35 (16/19) 34 (18/16) 0.77
Age (yrs) 43 ± 13 39 ± 13 37 ± 13 42 ± 13 0.10
T1D duration (yrs) 24 ± 13 20 ± 14 28 ± 11 0.01
WHR (cm/cm) 0.86 ± 0.10 0.87 ± 0.08 0.82 ± 0.06 0.91 ± 0.08 0.0005
BMI (kg/m2) 26.7 ± 4.8 27.8 ± 6.5 24.8 ± 2.7 31.0 ± 7.7 0.0001
BP (mmHg) 121/69 ± 12/9 132/73 ±19/10 125/70 ± 11/7 140/75 ± 22/12 <0.0001/0.04
HbAlc (%) 5.2 ± 0.4, 8.1 ± 1.5 7.9 ± 1.2 8.3 ± 1.7 <0.0001
HbAlc (mmol/mol) 33.3 ± 4.7, 65.4 ± 16.4 63.2 ± 12.8 67.4 ± 19.1 <0.0001
1,5AG (μg/mL) 18.9 ± 9.2, 4.8 ± 3.2 4.1 ± 2.0 4.1 ± 3.9 0.0005
Total Cholesterol
(TC) (mM)
5.2 ± 1.1 4.7 ± 1.3 4.3 ± 0.8 5.1 ± 1.7 0.01
Fasting triglycerides
(TG) (mM)
1 (0.7, 1.4) 0.8 (0.6, 1.2) 0.7 (0.6, 1.0) 1.0 (0.8, 2.2) 0.01
HDL-C (mM) 1.5 ± 0.4 1.5 ± 0.4 1.5 ± 0.4 1.4 ± 0.5 0.81
LDL-C (mM) 3.2 ± 1.1 2.7 ± 1.1 2.4 ± 0.7 3.0 ± 1.4 0.02
eGFR (ml/min/1.73 m2) 111 (102, 120) 100 (84, 120) 104 (93, 124) 96 (78, 116) 0.06
hsCRP (mg/L) 0.7 (0.4, 1.2) 2.0 (0.5, 5.4) 1.2 (0.4, 3.2) 2.5 (1.2, 6.4) 0.003
eGDR (mg/kg/min) 10.5 ± 2.1, 7.4 ± 2.5 8.9 ± 1.7 5.7 ± 2.1 <0.0001
Smoking (current/ex/never) 3/10/19a 12/15/39a 10/6/18a 2/9/21a, 0.07
Retinopathy (Y/N/only) 28/41/8 28/6/8
Nephropathy (Y/N/only) 26/43/6 26/8/6

miR-142 Non-diabetic All T1D T1D-No
Cx
T1D-Cx Pb

miR-142 (raw) (mean ± SD) 1.25 ± 0.78 3.53 ± 3.66 2.68 ± 2.14 4.40 ± 4.62 0.0002
miR-142 (raw) (median (LQ, UQ)) 1.03 (0.77, 1.68), 2.61 (0.93, 5.19) 2.21 (0.80, 3.57) 3.00 (1.16, 6.05) 0.0002
Adjusted(1)
miR-142 (mean, 95% CI)
0.67 (−0.89, 2.24) 3.99 (2.79, 5.19) 3.12 (1.80, 4.44) 4.44 (3.02, 5.85) 0.01
Adjusted(2)
miR-142 (mean, 95% CI)
0.97 (−0.43, 2.37) 3.94 (2.80, 5.08) 2.95 (1.73, 4.16) 4.85 (3.58, 6.12) 0.0006

BOLD p < 0.05 Non-diabetic vs. All T1D.

Adjusted (1): BP, HbA1c, TC, LDL, eGFR, hsCRP, eGDR, Adjusted (2): Age, Sex, HbA1c.

a

Some data missing.

b

Non-diabetic vs. T1D-No Cx vs. T1D-Cx: ANOVA, Kruskal-Wallis ANOVA or χ2.

p < 0.05 vs. T1D-No Cx.

p < 0.05 vs. T1D-Cx.